Bempegaldesleukin
20-214-34
Phase 1 small_molecule completed
Quick answer
Bempegaldesleukin for Covid-19 is a Phase 1 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Covid-19
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed